Spermosens AB (publ) is listed on Spotlight Stock Market
The share is traded under the ticker SPERM and ISIN-code SE0015346424
Spermosens AB (publ) (“Spermosens” or the “Company”) presents the plan to achieve positive cash flow following a recent investment by a consortium of investors from Germany, Scandinavia and the United States. The plan includes completion of the ongoing clinical study and advancing the JUNO-Checked technology and system to ensure commercial viability. Through this approach, Spermosens…
Read more at CisionSpermosens AB (publ) ("Spermosens" or the "Company") today announces the outcome of the TO3 series of warrants, issued in connection with the rights issue announced on 20 February 2024.
Read more at CisionSpermosens AB (publ) (“Spermosens” or the “Company”) has secured an investment of SEK 10.8 million through a directed issue from a consortium of American and European strategic investors. The investment, which does not include issuance of any warrants, provides funding until H2 2026, when the Company expects to reach cash flow positivity, primarily through income…
Read more at CisionSpermosens AB ("Spermosens" or "the Company") announces that the last day of trading for the warrants of series TO3 on Spotlight Stock Market is 27 February 2025.
Read more at CisionSpermosens AB (publ) announces changes in its shareholding structure following the latest directed issue. An update of the shareholder structure was made prior to the extraordinary general meeting held on 17 February 2025.
Read more at CisionSpermosens AB (publ) höll den 17 februari 2025 extra bolagsstämma varvid i huvudsak följande beslut fattades. Beslut om ändring av bolagsordningen Den extra bolagsstämman beslutade, i enlighet med styrelsens förslag, att bemyndiga styrelsen att ändra bolagets bolagsordning genom att anta nya gränser för aktiekapitalet respektive antalet aktier i syfte att möjliggöra emission av aktier och…
Read more at CisionEminova Fondkommission AB
Biblioteksgatan 3, 3 tr.
111 46 Stockholm
Tel: +46 8 684 211 00
info@eminova.se